Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Finasteride for hair loss has minimal impact on sexual function.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Human alpha defensin 5 helps heal wounds, reduce bacteria, and grow hair on burned skin.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.